Spero Therapeutics, Inc.

SPRO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
EFFECT Mar 29, 2021
CORRESP Mar 24, 2021
10-K/A Mar 23, 2021 10-K/A
UPLOAD Mar 17, 2021
S-8 Mar 11, 2021 S-8
S-3 Mar 11, 2021 S-3
8-K Mar 11, 2021 8-K
10-K Mar 11, 2021 10-K
SC 13D/A Feb 16, 2021 AMENDED ACQUISITION OF BENEFICIAL OWNERSHIP
SC 13G/A Feb 16, 2021
SC 13G/A Feb 16, 2021 AMENDMENT NO. 3 TO THE SCHEDULE 13G
SC 13G/A Feb 10, 2021 SC 13G/A
4 Feb 10, 2021 PRIMARY DOCUMENT
8-K Feb 5, 2021 8-K
4 Feb 4, 2021 PRIMARY DOCUMENT
4 Feb 3, 2021 FORM 4 SUBMISSION
4 Feb 3, 2021 FORM 4 SUBMISSION
4 Feb 3, 2021 FORM 4 SUBMISSION
4 Feb 3, 2021 FORM 4 SUBMISSION
SC 13G Feb 2, 2021
SC 13G/A Feb 2, 2021 SC 13G/A
8-K Jan 19, 2021 8-K
4 Jan 6, 2021 FORM 4 SUBMISSION
4 Jan 6, 2021 FORM 4 SUBMISSION
4 Jan 6, 2021 FORM 4 SUBMISSION
← Newer Page 12 of 21 · 513 filings Older →